Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Wittbrodt

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Pain and Symptom Management|January 10, 2002
Low-dose oral naloxone reverses opioid-induced constipation and analgesiaMaywin Liu, Eric Wittbrodt
Pharmacotherapy|September 2, 2006
Treatment algorithms from the pharmacist perspectiveEric Wittbrodt, Peter Koval, Hengameh H Raissy, et al.
Journal of Opioid Management|March 12, 2019
Opioid utilization patterns among patients with cancer and non-cancer painCatherine J Datto, Yiqun Hu, Eric Wittbrodt, et al.
Diabetes, Obesity & Metabolism|October 31, 2017
All-cause and diabetes-related healthcare costs among US adults with type 2 diabetes initiating exenatide once weekly or insulin glargineEric Wittbrodt, Amanda M Kong, Laura Moore-Schiltz, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Impact of opioid use on patients undergoing screening colonoscopy according to the quality of bowel preparationLois Lamerato, Eric Wittbrodt, Manpreet Kaur, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 30, 2018
Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapyPerry G Fine, Yen-Wen Chen, Eric Wittbrodt, et al.
Diabetes, Obesity & Metabolism|April 11, 2019
Eligibility of patients with type 2 diabetes for sodium-glucose co-transporter-2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative RegistryEric Wittbrodt, David Chamberlain, Suzanne V Arnold, et al.
Pharmacoeconomics|February 18, 2015
The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USACharles Baum, Katherine Andino, Eric Wittbrodt, et al.
Orphanet Journal of Rare Diseases|January 17, 2025
Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature reviewDiego Delgado, Firas Dabbous, Nitin Shivappa, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 26, 2019
A Retrospective Claims Analysis of Dual Bronchodilator Fixed-Dose Combination Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary DiseaseCharlie Strange, Valery Walker, Junliang Tong, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Pain and Symptom Management|January 10, 2002
Low-dose oral naloxone reverses opioid-induced constipation and analgesiaMaywin Liu, Eric Wittbrodt
Pharmacotherapy|September 2, 2006
Treatment algorithms from the pharmacist perspectiveEric Wittbrodt, Peter Koval, Hengameh H Raissy, et al.
Journal of Opioid Management|March 12, 2019
Opioid utilization patterns among patients with cancer and non-cancer painCatherine J Datto, Yiqun Hu, Eric Wittbrodt, et al.
Diabetes, Obesity & Metabolism|October 31, 2017
All-cause and diabetes-related healthcare costs among US adults with type 2 diabetes initiating exenatide once weekly or insulin glargineEric Wittbrodt, Amanda M Kong, Laura Moore-Schiltz, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Impact of opioid use on patients undergoing screening colonoscopy according to the quality of bowel preparationLois Lamerato, Eric Wittbrodt, Manpreet Kaur, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 30, 2018
Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapyPerry G Fine, Yen-Wen Chen, Eric Wittbrodt, et al.
Diabetes, Obesity & Metabolism|April 11, 2019
Eligibility of patients with type 2 diabetes for sodium-glucose co-transporter-2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative RegistryEric Wittbrodt, David Chamberlain, Suzanne V Arnold, et al.
Pharmacoeconomics|February 18, 2015
The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USACharles Baum, Katherine Andino, Eric Wittbrodt, et al.
Orphanet Journal of Rare Diseases|January 17, 2025
Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature reviewDiego Delgado, Firas Dabbous, Nitin Shivappa, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 26, 2019
A Retrospective Claims Analysis of Dual Bronchodilator Fixed-Dose Combination Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary DiseaseCharlie Strange, Valery Walker, Junliang Tong, et al.
Pageof 4